PVR and cancer: reported the generation of hypoimmunogenic cancer-antigen-specific T cells derived from iPSCs lacking β2-microglobulin, the MHC class-II and the natural killer (NK) cell-ligand poliovirus receptor CD155, and expressing single-chain MHC class-I antigen E (19).